Company profile
Gliknik company profile
Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.
Business identity
- Website
- http://www.gliknik.com
- Phone number
- (410) 685-0662
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2007-01-01, Year
Headquarters
- Headquarters
- Rosedale, Indiana, United States
- Postal code
- 21201
- Country code
- US
- Continent
- North America